证券日报网讯 2月6日，药明康德（603259）在互动平台回答投资者提问时表示，2025年前三季度，公 司来自欧洲客户收入为38.4亿元，占公司持续经营业务收入的12%。 ...

（文章来源：证券日报） 证券日报网讯 2月6日，药明康德在互动平台回答投资者提问时表示，公司历来不自行开发新药，也没 有用AI来开发新药。 ...

Group 1 - The top three companies with the highest short positions are COSCO Shipping Holdings (01919), Dongfang Electric (01072), and Vanke Enterprises (02202), with short ratios of 18.70%, 16.91%, and 16.66% respectively [1][2] - The companies with the largest increase in short positions are Ganfeng Lithium (01772), Sanhua Intelligent Control (02050), and CATL (03750), with increases of 2.04%, 1.63%, and 1.51% respectively [1][2] - The companies with the largest decrease in short positions are Kanglong Chemical (03759), Aneng Logistics (09956), and Changfei Optical Fiber (06869), with decreases of -1.71%, -1.68%, and -1.01% respectively [1][3] Group 2 - The latest short position data shows that COSCO Shipping Holdings has 516 million shares short, up from 511 million shares previously, while Dongfang Electric has 68.99 million shares short, down from 70.83 million shares [2] - The companies with the largest short position increases include Ganfeng Lithium, which rose from 7.67% to 9.70%, and Sanhua Intelligent Control, which increased from 5.76% to 7.39% [2] - The companies with the largest short position decreases include Kanglong Chemical, which fell from 5.35% to 3.64%, and Aneng Logistics, which dropped from 2.68% to 1.00% [3][4]

Core Viewpoint - The report highlights the premium rates of AH shares, with Northeast Electric, Zhejiang Shibao, and Sinopec Oilfield Services leading in premium rates, while CATL, China Merchants Bank, and WuXi AppTec are at the bottom of the list [1][2][3]. Premium Rate Rankings - The top three AH shares by premium rate are: - Northeast Electric (00042) with a premium rate of 831.03% - Zhejiang Shibao (01057) with a premium rate of 353.97% - Sinopec Oilfield Services (01033) with a premium rate of 302.25% [2] - The bottom three AH shares by premium rate are: - CATL (03750) with a premium rate of -11.84% - China Merchants Bank (03968) with a premium rate of -3.56% - WuXi AppTec (02359) with a premium rate of 1.72% [3] Deviation Value Rankings - The top three shares by deviation value are: - Dazhu CNC (03200) with a deviation value of 60.25% - Muyuan Foods (02714) with a deviation value of 37.19% - Beijing Jingcheng Machinery Electric (00187) with a deviation value of 27.09% [1][4] - The bottom three shares by deviation value are: - Zhejiang Shibao (01057) with a deviation value of -39.99% - Junda Co., Ltd. (02865) with a deviation value of -35.13% - Yangtze Optical Fibre and Cable (06869) with a deviation value of -23.61% [1][5]

Core Viewpoint - WuXi AppTec is a leading international open-access capability and technology platform providing comprehensive and integrated new drug research and production services for the global biopharmaceutical industry [2]. Group 1: Company Overview - WuXi AppTec is a domestic leader in the pharmaceutical outsourcing industry and one of the earliest companies engaged in integrated CRO (Contract Research Organization) and CMO (Contract Manufacturing Organization) services [2]. - The company has a high-level management team with over 200 authorized and pending patent achievements [2]. - Its main business involves the discovery, research, and production of small molecule chemical drugs, offering a full range of integrated platform services to global pharmaceutical companies [2][7]. Group 2: Financial Performance - For the period from January to September 2025, WuXi AppTec achieved a revenue of 32.857 billion yuan, representing a year-on-year growth of 18.61% [7]. - The net profit attributable to the parent company was 12.076 billion yuan, showing a significant year-on-year increase of 84.84% [7]. - The company has distributed a total of 14.06 billion yuan in dividends since its A-share listing, with 10.406 billion yuan distributed over the past three years [8]. Group 3: Market Position and Trends - As of February 6, the stock price of WuXi AppTec increased by 0.74%, with a trading volume of 3.438 billion yuan and a turnover rate of 1.42%, leading to a total market capitalization of 291.901 billion yuan [1]. - The company benefits from a high overseas revenue ratio of 78.67%, which is positively impacted by the depreciation of the Chinese yuan [3]. - The average trading cost of the stock is 97.44 yuan, with the stock price approaching a resistance level of 98.02 yuan, indicating potential for upward movement if this level is surpassed [6].

Group 1 - The Hong Kong stock market for innovative drug concept stocks has experienced a significant upward trend, with notable gains in several companies [1] - Nocare Pharma (09969.HK) has seen an increase of over 10%, while Genscript Biotech (01672.HK) has risen by more than 7% [1] - Other companies such as Kelun-Biotech (06990.HK), Sihuan Pharmaceutical (02096.HK), and WuXi AppTec (02359.HK) have also followed suit with upward movements in their stock prices [1]

高盛 公司将 药明康德 A股评级上调至买进；目标价132.70元人民币。 ...

Core Viewpoint - The Hong Kong biotechnology sector is experiencing a significant upward trend, with notable gains in various stocks, indicating positive market sentiment in the industry [1] Group 1: Stock Performance - Nocare Biopharma (09969.HK) has seen an increase of over 4% [1] - Other companies such as Zai Lab (09688.HK), WuXi AppTec (02359.HK), WuXi Biologics (02269.HK), and Innovent Biologics (02696.HK) are also witnessing upward movement in their stock prices [1]

Core Viewpoint - The report highlights the premium rates of AH shares, with Northeast Electric, Zhejiang Shibao, and Sinopec Oilfield Services leading in premium rates, while CATL, China Merchants Bank, and WuXi AppTec are at the bottom of the list [1][2]. Premium Rate Rankings - The top three AH shares by premium rate are: - Northeast Electric (00042) with a premium rate of 815.25% - Zhejiang Shibao (01057) with a premium rate of 351.07% - Sinopec Oilfield Services (01033) with a premium rate of 303.37% [2] - The bottom three AH shares by premium rate are: - CATL (03750) with a premium rate of -12.99% - China Merchants Bank (03968) with a premium rate of -1.83% - WuXi AppTec (02359) with a premium rate of 3.29% [2] Deviation Values - The top three shares by deviation value are: - Guoen Technology (02768) with a deviation value of 64.57% - Goldwind Technology (02208) with a deviation value of 30.74% - Sinopec Oilfield Services (01033) with a deviation value of 27.72% [1][2] - The bottom three shares by deviation value are: - Junda Co., Ltd. (02865) with a deviation value of -49.44% - Zhejiang Shibao (01057) with a deviation value of -46.76% - Yangtze Optical Fibre and Cable (06869) with a deviation value of -34.58% [1][3].

Core Viewpoint - WuXi AppTec is experiencing growth due to its position as a leading Contract Research Organization (CRO) and its benefits from the depreciation of the Renminbi, with a significant portion of its revenue coming from overseas markets [2][3]. Company Overview - WuXi AppTec is an international leader in providing integrated new drug research and production services for the global biopharmaceutical industry, focusing on small molecule chemical drug discovery, development, and production [2]. - The company has a comprehensive platform service model that caters to global pharmaceutical companies, including medical device testing and precision medical research and production services abroad [2]. - As of September 30, 2025, WuXi AppTec reported a revenue of 32.857 billion yuan, representing a year-on-year growth of 18.61%, and a net profit of 12.076 billion yuan, with an impressive growth of 84.84% [7]. Financial Performance - The company’s overseas revenue accounted for 78.67% of its total revenue, benefiting from the depreciation of the Renminbi [3]. - The main business revenue composition includes chemical business (78.37%), testing business (12.93%), biological business (6.02%), and other services [7]. - WuXi AppTec has distributed a total of 14.06 billion yuan in dividends since its A-share listing, with 10.406 billion yuan distributed over the past three years [8]. Market Activity - On February 4, the stock price of WuXi AppTec increased by 1.07%, with a trading volume of 3.14 billion yuan and a turnover rate of 1.34%, leading to a total market capitalization of 285.277 billion yuan [1]. - The stock has seen a net inflow of 118 million yuan from major investors, indicating a positive sentiment in the market [4][5].